Company Filing History:
Years Active: 1998-2001
Title: Simon Mark Lumb: Innovator in Phosphodiesterase Research
Introduction
Simon Mark Lumb is a notable inventor based in Maidenhead, GB. He has made significant contributions to the field of biochemistry, particularly in the area of phosphodiesterase research. With a total of 2 patents to his name, Lumb's work has implications for both therapeutic and research applications.
Latest Patents
Lumb's latest patents focus on recombinant human phosphodiesterase type IVC. This invention describes the production and use of the enzyme, including the identification of specific conformers such as R- and S-rolipram stereoselective conformers. These conformers can be obtained by expressing human phosphodiesterase type IVC DNA in mammalian or insect cells. The recombinant enzyme has potential applications in screening compounds that can modulate its action or serve as an immunogen for generating antibodies.
Career Highlights
Simon Mark Lumb is currently associated with Celltech Therapeutics Limited, where he continues to advance his research in enzyme technology. His work has contributed to the understanding of phosphodiesterases and their role in various biological processes.
Collaborations
Lumb has collaborated with notable colleagues such as Raymond John Owens and Martin John Perry. These partnerships have fostered innovation and have been instrumental in the development of his research projects.
Conclusion
Simon Mark Lumb is a distinguished inventor whose work in phosphodiesterase research has led to valuable patents and collaborations. His contributions continue to impact the field of biochemistry and therapeutic development.